UK recognises Covaxin as valid COVID-19 vaccine for travel
The approval of Covaxin follows the WHO Emergency Use Listing for the vaccine
Read More
Author: Iona Everson
EMA supports molnupiravir prior to formal authorisation
The oral antiviral drug is for the treatment of patients with COVID-19
Read More- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
